About Us

banner_std

About Us

Ondek® is a private Australian company founded by Nobel Laureate Professor Barry Marshall to develop new medicines by exploiting the immuno-modulatory properties of the bacterium Helicobacter pylori.

Professor Marshall is a world renowned authority on H. pylori and a co-recipient of the 2005 Nobel Prize in Physiology or Medicine for the co-discovery that H. pylori plays a major role in causing many peptic ulcers, upsetting decades-old medical doctrine at the time.

The company is developing an oral therapeutic candidate, ImmBALANCE®, derived from H. pylori, to treat paediatric allergy – which frequently manifests initially as atopic dermatitis (also known as eczema) and may progress to include food allergies, allergic asthma, allergic rhinitis and other allergic conditions.